Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,449 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
UPLOAD File 000-19034

UPLOAD filing

Filing date
17 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 000-19034

PRELIMINARY PROXY STATEMENT

Filing date
07 Apr 2025
Reporting date
13 Jun 2025
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 000-19034

UPLOAD filing

Filing date
21 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-41938

SCHEDULE 13G/A filing

Filing date
12 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
13F-HR File 028-24826

13F-HR filing

Filing date
07 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .